Revolution Medicines, Inc. (RVMDW) stock
RVMDWNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31Also trades as RVMD
$9.81+0.18 (+1.82%)
Close on Oct 30, 2026Market cap $41.00BP/E –Yield –
Revolution Medicines statistics
64 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- Nov 4, 2026 (estimated, after the close)
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- Oct 30, 2026
Valuation ratiosIndustry
- P/TBV Ratio
- 16.17
- 2.47
Share statisticsIndustry
- Shares Change (YoY)
- 10.4%
- 10.8%
- Shares Change (QoQ)
- 7.03%
- 0.54%
- Float
- 203M
- 49M
- Shares Held by Insiders
- 5.31%
- 11.4%
- Shares Held by Institutions
- 104.6%
- 56.1%
Short sellingIndustry
- Short Interest
- 12M
- –
- Short Interest Change
- 23.3%
- 0.60%
- Days to Cover
- 4.65
- 4.58
Stock price statisticsIndustry
- 52-Week High
- $224.31
- –
- 52-Week Low
- $56.66
- –
- 20-Day Moving Average
- $190.88
- –
- 50-Day Moving Average
- $199.22
- –
- 200-Day Moving Average
- $156.04
- –
- Average True Range (14)
- $8.13
- –
- Price Change (1 Week)
- 2.31%
- 1.30%
- Price Change (1 Month)
- -7.08%
- -7.60%
- Price Change (3 Months)
- 4.86%
- -14.4%
- Price Change (6 Months)
- 37.2%
- -19.7%
- Price Change (YTD)
- 140.2%
- -19.6%
- Price Change (1 Year)
- 229.7%
- -21.9%
- Price Change (3 Years)
- 866.2%
- -22.6%
- Price Change (5 Years)
- 550.1%
- -75.5%
- Average Volume (10 Days)
- 2M
- –
- Average Volume (20 Days)
- 2M
- –
- Average Volume (90 Days)
- 2M
- –
- Relative Volume
- 0.51
- 0.73
- Relative Strength Index (14)
- 48.7
- 44.2
- Volatility (1 Year)
- 66.6%
- 79.5%
- Beta (5 Years)
- 1.37
- 1.07
Returns on capitalIndustry
- Return on Equity (ROE)
- -79.1%
- -53.1%
- Return on Assets (ROA)
- -52.4%
- -40.9%
- Return on Capital Employed (ROCE)
- -41.0%
- -38.6%
Financial positionIndustry
- Current Ratio
- 11.38
- 3.30
- Quick Ratio
- 11.12
- 2.39
- Interest Coverage
- -27.42
- -6.26
EfficiencyIndustry
- Profits Per Employee
- -$2.00M
- -$705.27K
- Employee Count
- 883
- 75
- WACC
- 11.8%
- 10.1%
Income statement (TTM)Industry
- Pretax Income
- -$1.77B
- -$14.23M
Balance sheetIndustry
- Net Cash (Debt)
- $3.94B
- $15.31M
- Net Cash Per Share
- $18.37
- $0.66
- Equity (Book Value)
- $2.61B
- $48.79M
- Book Value Per Share
- $12.16
- $1.36
- Tangible Book Value
- $2.54B
- $23.91M
- Working Capital
- $3.67B
- $74.41M
Cash flow (TTM)Industry
- Capital Expenditures
- -$9.10M
- -$1.07M
- FCF Per Share
- -$5.75
- -$0.41
Dividends and yieldsIndustry
- Earnings Yield
- -4.31%
- -20.7%
- FCF Yield
- -3.00%
- -8.69%
Taxes and interestIndustry
- Interest Expense
- $59.34M
- $3.07M
Scores and fair valueIndustry
- Altman Z-Score
- 12.82
- 0.25
- Piotroski F-Score
- 2
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.
| Period | RVMDW | S&P 500 | Difference | RVMDW per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -14.2% | -0.9% | −13.3 pts | ||
| 3 months | -0.7% | +2.1% | −2.9 pts | ||
| Year to date | +943.7% | +11.7% | +932.0 pts | ||
| 1 year | +2306.2% | +12.4% | +2293.8 pts |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 15, 2026.
0M RVMDW shares were sold short on Oct 15, 2026, up 106.3% from the previous report. At recent volumes it would take 1.0 days to buy them back. Over the last 20 sessions, 59.0% of the volume reported to FINRA was short selling.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Oct 15, 2026 | 1,578 | +106.3% | 19,075 | 1.0 |
| Sep 30, 2026 | 765 | +8.8% | 39,697 | 1.0 |
| Sep 15, 2026 | 703 | -64.9% | 25,844 | 1.0 |
| Aug 31, 2026 | 2,000 | +139.2% | 54,704 | 1.0 |
| Aug 14, 2026 | 836 | -27.5% | 64,009 | 1.0 |
| Jul 31, 2026 | 1,153 | -47.6% | 16,349 | 1.0 |
| Jul 15, 2026 | 2,202 | -29.3% | 27,859 | 1.0 |
| Jun 30, 2026 | 3,115 | +127.5% | 95,598 | 1.0 |
| Jun 15, 2026 | 1,369 | -32.2% | 92,221 | 1.0 |
| May 29, 2026 | 2,018 | -13.3% | 57,784 | 1.0 |
| May 15, 2026 | 2,327 | +13.6% | 117,561 | 1.0 |
| Apr 30, 2026 | 2,049 | -26.5% | 207,893 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.